NewsRx

Search our medical news database

Advanced Viral Research Corp.

Seventeenth patent granted to biotech company

Published in Medicine and Law Weekly, June 24th, 2005

Advanced Viral Research Corp. (ADVR) announced that the patent office in China has granted the company patent #ZL 00811493.5 entitled "Preparation of a Therapeutic Composition" for AVR118.

The patent describes the composition of AVR118 and methods of manufacturing it.

"Developing a strong worldwide intellectual property estate is critical in the field of biotechnology," said Elma S. Hawkins, president and CEO of Advanced Viral Research Corp. "This is our second patent granted in China for AVR118, thereby providing additional protection for our flagship product."

Currently, ADVR is engaged in a phase II, multicenter, randomized,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook